<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MM22RPD" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
Open Mobile Menu
rows
Home
chevronright
chevronleft
Products
chevronright
Current Page
INVEGA HAFYERA®
(paliperidone palmitate 6-month)
Search INVEGA HAFYERA...
Search
search
INVEGA HAFYERA® (paliperidone palmitate 6-month)
icon-pdf
Full Prescribing Information including BOXED WARNING (English)
icon-pdf
Full Prescribing Information including BOXED WARNING (Spanish)
icon-resources-med-search
Search Medical Information
icon-resources-links
Useful Links
Clinical Trial Publications
Najarian D, Sanga P, Wang S, et al. A randomized, double-blind, multicenter, noninferiority study comparing paliperidone palmitate 6-month versus the 3-month long-acting injectable in patients with schizophrenia [published online ahead of print, 2021 Nov 13].
Int J Neuropsychopharmacol
. 2021. doi: 10.1093/ijnp/pyab071.